MicroRNA-9 suppresses cell migration and invasion through downregulation of TM4SF1 in colorectal cancer

International Journal of Oncology - Tập 48 Số 5 - Trang 2135-2413 - 2016
Sang Wook Kim1, Soo Teik Lee1, Se Lim Kim1, Yu Chuan Liu1, Min Ro Lee2, Ja Hyun Shin3, Seung Young Seo1, Seong‐Hun Kim1, In Hee Kim1, Seung Ok Lee1, Sang Wook Kim1
1Department of Internal Medicine, Chonbuk National University Hospital, Chonbuk National University Medical School, Jeonju, Republic of Korea
2Research Institute of Clinical Medicine of Chonbuk National University-Biomedical Research Institute, Chonbuk National University Hospital, Chonbuk National University Medical School, Jeonju, Republic of Korea
3Department of Nursing Science, Vision University College of Jeonju, Jeonju, Republic of Korea

Tóm tắt

Từ khóa


Tài liệu tham khảo

Siegel, 2014, Cancer statistics, 2014, CA Cancer J Clin, 64, 9, 10.3322/caac.21208

O'Connell, 2008, Survival following recurrence in stage II and III colon cancer: Findings from the ACCENT data set, J Clin Oncol, 26, 2336, 10.1200/JCO.2007.15.8261

Hellstrom, 1986, Monoclonal mouse antibodies raised against human lung carcinoma, Cancer Res, 46, 3917

O'Donnell, 1998, L6 monoclonal antibody binds prostate cancer, Prostate, 37, 91, 10.1002/(SICI)1097-0045(19981001)37:2<91::AID-PROS5>3.0.CO;2-O

Wright, 2000, The L6 membrane proteins - a new four-transmembrane superfamily, Protein Sci, 9, 1594, 10.1110/ps.9.8.1594

Chang, 2005, CD13 (aminopeptidase N) can associate with tumor-associated antigen L6 and enhance the motility of human lung cancer cells, Int J Cancer, 116, 243, 10.1002/ijc.21089

Lekishvili, 2008, The tumour-associated antigen L6 (L6-Ag) is recruited to the tetraspanin-enriched microdomains: Implication for tumour cell motility, J Cell Sci, 121, 685, 10.1242/jcs.020347

Kao, 2003, Tumor-associated antigen L6 and the invasion of human lung cancer cells, Clin Cancer Res, 9, 2807

Marken, 1992, Cloning and expression of the tumor-associated antigen L6, Proc Natl Acad Sci USA, 89, 3503, 10.1073/pnas.89.8.3503

Allioli, 2011, TM4SF1, a novel primary androgen receptor target gene over-expressed in human prostate cancer and involved in cell migration, Prostate, 71, 1239, 10.1002/pros.21340

Otsuka, 2001, Differential expression of the L-plastin gene in human colorectal cancer progression and metastasis, Biochem Biophys Res Commun, 289, 876, 10.1006/bbrc.2001.6047

Ying, 2006, The microRNA: Overview of the RNA gene that modulates gene functions, Methods Mol Biol, 342, 1

Wang, 2010, hsa-miR-520h downregulates ABCG2 in pancreatic cancer cells to inhibit migration, invasion, and side populations, Br J Cancer, 103, 567, 10.1038/sj.bjc.6605724

Zhou, 2015, The roles of microRNAs in the regulation of tumor metastasis, Cell Biosci, 5, 32, 10.1186/s13578-015-0028-8

Aguda, 2008, MicroRNA regulation of a cancer network: Consequences of the feedback loops involving miR-17–92, E2F, and Myc, Proc Natl Acad Sci USA, 105, 19678, 10.1073/pnas.0811166106

Grady, 2008, Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer, Oncogene, 27, 3880, 10.1038/onc.2008.10

Mo, 2015, MicroRNA 196B regulates FAS-mediated apoptosis in colorectal cancer cells, Oncotarget, 6, 2843, 10.18632/oncotarget.3066

Hoffman, 2009, microRNA miR-196a-2 and breast cancer: A genetic and epigenetic association study and functional analysis, Cancer Res, 69, 5970, 10.1158/0008-5472.CAN-09-0236

Aqeilan, 2010, miR-15a and miR-16-1 in cancer: Discovery, function and future perspectives, Cell Death Differ, 17, 215, 10.1038/cdd.2009.69

Zhang, 2015, Down-regulation of microRNA-9 leads to activation of IL-6/Jak/STAT3 pathway through directly targeting IL-6 in HeLa cell, Mol Carcinog

Mohammadi-Yeganeh, 2015, Targeting of miR9/NOTCH1 interaction reduces metastatic behavior in triple-negative breast cancer, Chem Biol Drug Des, 86, 1185, 10.1111/cbdd.12584

Laios, 2008, Potential role of miR-9 and miR-223 in recurrent ovarian cancer, Mol Cancer, 7, 35, 10.1186/1476-4598-7-35

Higashi, 2015, miR-9-3p plays a tumour-suppressor role by targeting TAZ (WWTR1) in hepatocellular carcinoma cells, Br J Cancer, 113, 252, 10.1038/bjc.2015.170

Luo, 2009, Down-regulated miR-9 and miR-433 in human gastric carcinoma, J Exp Clin Cancer Res, 28, 82, 10.1186/1756-9966-28-82

Tagawa, 2012, Multiple microRNAs induced by Cdx1 suppress Cdx2 in human colorectal tumour cells, Biochem J, 447, 449, 10.1042/BJ20120434

Zhu, 2015, Regulation of UHRF1 by microRNA-9 modulates colorectal cancer cell proliferation and apoptosis, Cancer Sci, 106, 833, 10.1111/cas.12689

Sarver, 2009, Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states, BMC Cancer, 9, 401, 10.1186/1471-2407-9-401

Slattery, 2015, An evaluation and replication of miRNAs with disease stage and colorectal cancer-specific mortality, Int J Cancer, 137, 428, 10.1002/ijc.29384

Bandres, 2009, Epigenetic regulation of microRNA expression in colorectal cancer, Int J Cancer, 125, 2737, 10.1002/ijc.24638

Rotkrua, 2011, MiR-9 downregulates CDX2 expression in gastric cancer cells, Int J Cancer, 129, 2611, 10.1002/ijc.25923

Kim, 2015, Parthenolide enhances sensitivity of colorectal cancer cells to TRAIL by inducing death receptor 5 and promotes TRAIL-induced apoptosis, Int J Oncol, 46, 1121, 10.3892/ijo.2014.2795

Liu, 2010, The role of NF-kappaB in Hepatitis b virus X protein-mediated upregulation of VEGF and MMPs, Cancer Invest, 28, 443, 10.3109/07357900903405959

Kim, 2011, Celastrol inhibits breast cancer cell invasion via suppression of NF-κB-mediated matrix metalloproteinase-9 expression, Cell Physiol Biochem, 28, 175, 10.1159/000331729

Lu, 2005, MicroRNA expression profiles classify human cancers, Nature, 435, 834, 10.1038/nature03702

Landgraf, 2007, A mammalian microRNA expression atlas based on small RNA library sequencing, Cell, 129, 1401, 10.1016/j.cell.2007.04.040

Duffy, 2000, Metalloproteinases: Role in breast carcinogenesis, invasion and metastasis, Breast Cancer Res, 2, 252, 10.1186/bcr65

Hanemaaijer, 2000, Increased gelatinase-A and gelatinase-B activities in malignant vs. benign breast tumors, Int J Cancer, 86, 204, 10.1002/(SICI)1097-0215(20000415)86:2<204::AID-IJC9>3.0.CO;2-6

Chambers, 1997, Changing views of the role of matrix metalloproteinases in metastasis, J Natl Cancer Inst, 89, 1260, 10.1093/jnci/89.17.1260

Mc Donnell, 1999, Metastatic and non-metastatic colorectal cancer (CRC) cells induce host metalloproteinase production in vivo, Clin Exp Metastasis, 17, 341, 10.1023/A:1006651019335

Shih, 2009, The L6 protein TM4SF1 is critical for endothelial cell function and tumor angiogenesis, Cancer Res, 69, 3272, 10.1158/0008-5472.CAN-08-4886

Nass, 2009, MiR-92b and miR-9/9* are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumors, Brain Pathol, 19, 375, 10.1111/j.1750-3639.2008.00184.x

Ma, 2010, miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis, Nat Cell Biol, 12, 247, 10.1038/ncb2024

Shiiyama, 2013, Sensitive detection of melanoma metastasis using circulating microRNA expression profiles, Melanoma Res, 23, 366, 10.1097/CMR.0b013e328363e485

Song, 2014, MicroRNA-9 promotes tumor metastasis via repressing E-cadherin in esophageal squamous cell carcinoma, Oncotarget, 5, 11669, 10.18632/oncotarget.2581